The incidence and impact of atrial fibrillation on hospitalized Coronavirus disease‐2019 patients

• Published in: Clinical cardiology (Mahwah, N.J.) N.J.), 2024-02, Vol.47 (2), p.e24240-n/a
• Main Authors: Niu, Haiming, Li, Jianwei, Teng, Catherine, Lu, Xiaojia, Jin, Chengyue, Cai, Peng, Shi, Ao, Shen, Xiaoqing, Chen, Qiqi, Chen, Miaolian, Yuan, Yong, Li, Pengyang
• Format: Article
• Language: English
• Subjects: atrial fibrillation; Atrial Fibrillation - diagnosis; Atrial Fibrillation - epidemiology; Cardiac arrhythmia; Cardiovascular disease; Chronic obstructive pulmonary disease; Clinical; Coronary vessels; Coronavirus; Coronaviruses; COVID-19; COVID-19 - complications; COVID-19 - epidemiology; Demographics; Diabetes; Family income; Hospitals; Humans; Hyperlipidemia; Hypertension; Incidence; in‐hospital complication; Kidney diseases; Male; Medical research; Middle Aged; mortality; Patients; Population; Retrospective Studies; Sleep apnea; Statistical analysis; Vein & artery diseases
• ISSN: 0160-9289; 1932-8737; 1932-8737
• DOI: 10.1002/clc.24240

Background Since 2019, Coronavirus disease‐2019 (COVID‐19) has raised unprecedented global health crisis. The incidence and impact of atrial fibrillation (AF) on patients with COVID‐19 remain unclearly defined. Methods We conducted a retrospective cohort study using ICD‐10 codes to identify patients with a primary diagnosis of COVID‐19 with or without AF in National Inpatient Sample Database 2020. We compared the outcome of COVID‐19 patients with a concurrent diagnosis of AF with those without. Hypothesis AF will adversely affect the prognosis of hospitalized COVID‐19 patients. Results A total of 211 619 patients with a primary diagnosis of COVID‐19 were identified. Among these patients, 31 923 (15.08%) had a secondary diagnosis of AF. Before propensity score matching, COVID‐AF cohort was older (75.8 vs. 62.2‐year‐old, p